SCOTT DOLL: Open Payments
NPI 1033685847 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,549 in 117 payments from 33 companies in 2025. Trend: 2023 $889 · 2024 $1,830 · 2025 $2,549
Food & beverage: $2,531Education: $18
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 13 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $220 |
| HARMONY BIOSCIENCES LLC | 11 | $202 |
| PFIZER INC. | 9 | $158 |
| Janssen Biotech, Inc. | 8 | $158 |
| ABBVIE INC. | 6 | $152 |
| ARGENX US, INC. | 5 | $120 |
| Lilly USA, LLC | 6 | $119 |
| UCB, Inc. | 4 | $105 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $94 |
Products named: Leqembi, HYQVIA, WAKIX, NURTEC ODT, VYVGART HYTRULO, LUMRYZ, QULIPTA, UBRELVY.
Industry payments across FL — which companies pay providers there.
